AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23829890 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but includes all arms)
Number of subjects: 208
Study 20890204 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus retraining therapy (TRT) with acoustic stimulation devices and 3 months of individual counseling
Number of subjects: 0
Study 20890204 — intervention group
Group type: COMPARATOR
Intervention: General counseling without additional sound therapy
Number of subjects: 0
Study 18792423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling
Number of subjects: 62
Study 18792423 — intervention group
Group type: COMPARATOR
Intervention: Individual counselling
Number of subjects: 62
Study 18792423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 16548952 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer integrated patient controlled epidural analgesia (CI‐PCEA)
Number of subjects: 40
Study 16548952 — intervention group
Group type: COMPARATOR
Intervention: Demand only patient controlled epidural analgesia (PCEA)
Number of subjects: 40
Study 12732396 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriers of the 53A allele
Number of subjects: 0
Study 12732396 — intervention group
Group type: COMPARATOR
Intervention: 53G homozygotes
Number of subjects: 0
Study 12732396 — intervention group
Group type: COMPARATOR
Intervention: L125V polymorphism
Number of subjects: 0
Study 11269551 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoGIA laparoscopic appendectomy
Number of subjects: 150
Study 11269551 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoloop laparoscopic appendectomy
Number of subjects: 150
Study 11269551 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal laparoscopically assisted appendectomy
Number of subjects: 150
Study 9699090 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urinary albumin excretion (UAE)
Number of subjects: 320
Study 8120515 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and vitamin E treatment (1.6 mg selenium and 800 mg vitamin E daily for 4 months)
Number of subjects: 27
Study 8120515 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (corresponding number of placebo tablets)
Number of subjects: 27
Study 2680285 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenticonazole ovule (600 mg)
Number of subjects: 50
Study 2680285 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablet (500 mg)
Number of subjects: 50
Study 1106277 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (3 to 4 mg/kg of body weight) plus prednisone (60 mg per day initially)
Number of subjects: 24
Study 1106277 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (60 mg per day initially)
Number of subjects: 24
Study 7217546 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training plus methylphenidate
Number of subjects: 43
Study 7217546 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate only
Number of subjects: 43
Study 7217546 — intervention group
Group type: COMPARATOR
Intervention: Parent training in behavior modification with placebo
Number of subjects: 43
Study 31933482 — intervention group
Group type: EXPERIMENTAL
Intervention: DRV+COBI
Number of subjects: 36
Study 31933482 — intervention group
Group type: EXPERIMENTAL
Intervention: ATV+COBI
Number of subjects: 36
Study 31933482 — intervention group
Group type: COMPARATOR
Intervention: drospirenone/EE
Number of subjects: 36
Study 30100300 — intervention group
Group type: EXPERIMENTAL
Intervention: Active joint motion foam rolling
Number of subjects: 30
Study 30100300 — intervention group
Group type: COMPARATOR
Intervention: No joint motion foam rolling
Number of subjects: 30
Study 28479909 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized education (one-on-one counseling and individualized management plan)
Number of subjects: 280
Study 28479909 — intervention group
Group type: COMPARATOR
Intervention: Group education (control group)
Number of subjects: 280
Study 24445089 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of backward walking exercise and alpha-lipoic acid (ALA) treatment (ALA for 2 weeks, backward walking exercise for 12 weeks)
Number of subjects: 60
Study 24445089 — intervention group
Group type: COMPARATOR
Intervention: Alpha-lipoic acid (ALA) treatment (control group)
Number of subjects: 60
Study 24445089 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of backward walking exercise and alpha-lipoic acid (ALA) treatment
Number of subjects: 60
Study 24445089 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward walking exercise
Number of subjects: 60
Study 23098173 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispositional catastrophizing ratings (pre-to-post changes)
Number of subjects: 57
Study 23098173 — intervention group
Group type: EXPERIMENTAL
Intervention: Situational catastrophizing ratings (pre-to-post changes)
Number of subjects: 57
Study 20335368 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-fluorouracil plus cetuximab
Number of subjects: 442
Study 20335368 — intervention group
Group type: COMPARATOR
Intervention: Platinum-fluorouracil
Number of subjects: 442
Study 17701403 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant
Number of subjects: 76
Study 16304254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal or inhaled beclomethasone dipropionate (BDP) administered separately or in combination for 16 weeks after a 2-week placebo run-in period
Number of subjects: 74
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary hemodynamics assessment
Number of subjects: 120
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac index assessment
Number of subjects: 120
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of mean pulmonary artery pressure
Number of subjects: 120
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple stepwise regression analysis
Number of subjects: 120
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of diastolic ventricular pressures
Number of subjects: 120
Study 12153963 — intervention group
Group type: EXPERIMENTAL
Intervention: Conclusions drawn from the study
Number of subjects: 120
Study 10981083 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to a diastolic blood pressure of less than or equal to 80 mm Hg
Number of subjects: 0
Study 10981083 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to a blood pressure goal of less than 150/85 mm Hg
Number of subjects: 0
Study 10981083 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to the lowest diastolic blood pressure goal of less than or equal to 80 mm Hg
Number of subjects: 0
Study 10981083 — intervention group
Group type: EXPERIMENTAL
Intervention: Attainment of lower blood pressure goal
Number of subjects: 0
Study 8551116 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloidal dressing
Number of subjects: 30
Study 8551116 — intervention group
Group type: COMPARATOR
Intervention: Rice paper patch
Number of subjects: 30
Study 1983509 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - Embolex‐LM, n = 464
Number of subjects: 1510
Study 1983509 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin (Liquemin), n = 452
Number of subjects: 1510
Study 1983509 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - Sandoparin, n = 298
Number of subjects: 1510
Study 1983509 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin, n = 296
Number of subjects: 1510
Study 1983509 — intervention group
Group type: EXPERIMENTAL
Intervention: Excluded patients (not receiving thromboembolic prophylaxis)
Number of subjects: 1510
Study 354325 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluspirilene every week
Number of subjects: 34
Study 354325 — intervention group
Group type: COMPARATOR
Intervention: Fluspirilene every two weeks
Number of subjects: 34
Study 31726494 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal artery occlusion (RAO) patients
Number of subjects: 41
Study 27386813 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training group (resistance + aerobic)
Number of subjects: 20
Study 27386813 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training group (AG)
Number of subjects: 20
Study 25773496 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK256073 5mg BID
Number of subjects: 94
Study 25773496 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK256073 10mg QD
Number of subjects: 94
Study 25773496 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK256073 25mg BID
Number of subjects: 94
Study 25773496 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK256073 50mg QD
Number of subjects: 94
Study 25773496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 25773496 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK256073 (all doses)
Number of subjects: 94
Study 23344510 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy cholecystectomy (MC)
Number of subjects: 127
Study 23344510 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 127
Study 21198828 — intervention group
Group type: EXPERIMENTAL
Intervention: HALF index model for predicting significant fibrosis (SF)
Number of subjects: 208
Study 21198828 — intervention group
Group type: COMPARATOR
Intervention: Transient elastography (TE)
Number of subjects: 208
Study 19169102 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic stable intramedullary nailing (ESIN)
Number of subjects: 60
Study 19169102 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (simple shoulder sling)
Number of subjects: 60
Study 17222813 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E(+): 10 mg/day)
Number of subjects: 64
Study 17222813 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (L(+): 50 mg/day)
Number of subjects: 64
Study 17222813 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril + Losartan (E(+)L(+): 10 mg/day + 50 mg/day)
Number of subjects: 64
Study 17222813 — intervention group
Group type: COMPARATOR
Intervention: No medication (E(-)L(-))
Number of subjects: 64
Study 15563440 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day iron supplementation
Number of subjects: 25
Study 15563440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11740293 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PAD
Number of subjects: 14
Study 9241004 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day
Number of subjects: 34
Study 9241004 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 100 mg three times daily
Number of subjects: 34
Study 9241004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 8347437 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole (10 mg od)
Number of subjects: 158
Study 8347437 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine (10 mg od)
Number of subjects: 158
Study 3521559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (200 micrograms/kg, single oral dose)
Number of subjects: 30
Study 3521559 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (administered for eight days)
Number of subjects: 30
Study 3521559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31625041 — intervention group
Group type: EXPERIMENTAL
Intervention: Systems-level approach with MA-delivered health coaching sessions
Number of subjects: 119
Study 31625041 — intervention group
Group type: COMPARATOR
Intervention: Standard health coaching procedures (Control)
Number of subjects: 119
Study 30047223 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop (CL) insulin pump delivery
Number of subjects: 24
Study 30047223 — intervention group
Group type: COMPARATOR
Intervention: Threshold-low-glucose-suspend (TLGS) insulin pump delivery
Number of subjects: 24
Study 29070640 — intervention group
Group type: EXPERIMENTAL
Intervention: BETSILE programme
Number of subjects: 288
Study 29070640 — intervention group
Group type: COMPARATOR
Intervention: SILE programme
Number of subjects: 288
Study 26905985 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of magnesium sulphate intravenously
Number of subjects: 30
Study 26905985 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study 24071760 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling (once a week) and text messaging (five times a week) using stages of change
Number of subjects: 48
Study 24071760 — intervention group
Group type: COMPARATOR
Intervention: Traditional telephone counseling (once a month)
Number of subjects: 48
Study 21862166 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 6005
Study 21862166 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphonylureas
Number of subjects: 6005
Study 21862166 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin and Sulphonylureas
Number of subjects: 6005
Study 18972927 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinating immediately before DRE
Number of subjects: 200
Study 17124817 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound bed preparation
Number of subjects: 0
Study 14531593 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 1.5 mol/L aqueous solution of CaCl2 followed by 1.0 mol/L aqueous K3PO4
Number of subjects: 30
Study 14531593 — intervention group
Group type: COMPARATOR
Intervention: Topical application of 1.0 mol/L aqueous solution of KCl followed by distilled water
Number of subjects: 30
Study 11003455 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg/day for 3 days)
Number of subjects: 16
Study 11003455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8840843 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oils (5.4 g n‐3 fatty acids)
Number of subjects: 814
Study 8840843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 814
Study 8840843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (30 mg SC BID)
Number of subjects: 814
Study 8840843 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 814
Study 1309968 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg of ASA
Number of subjects: 27
Study 1309968 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 27
Study 6851195 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen-progestagen oral contraceptives
Number of subjects: 0
Study 6851195 — intervention group
Group type: COMPARATOR
Intervention: Essential hypertension (control group)
Number of subjects: 0
Study 30777514 — intervention group
Group type: EXPERIMENTAL
Intervention: Low probability of outcome following a predicting stimulus
Number of subjects: 0
Study 30777514 — intervention group
Group type: COMPARATOR
Intervention: High probability of outcome following a predicting stimulus
Number of subjects: 0
Study 29288740 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted mindfulness smoking cessation intervention with contingency management (SMI-CM)
Number of subjects: 8
Study 29288740 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard treatment plus non-contingent contingency management (EST)
Number of subjects: 8
Study 26332293 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 1376
Study 26332293 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 1376
Study 26332293 — intervention group
Group type: COMPARATOR
Intervention: Crossover from rhythm to rate control
Number of subjects: 1376
Study 26332293 — intervention group
Group type: COMPARATOR
Intervention: Crossover from rate to rhythm control
Number of subjects: 1376
Study 23964146 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito alone
Number of subjects: 22
Study 23964146 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito plus PPI (lansoprazole)
Number of subjects: 22
Study 23964146 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito
Number of subjects: 22
Study 21746974 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment (ET) for type 1 ROP
Number of subjects: 317
Study 21746974 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM) for type 1 ROP
Number of subjects: 317
Study 21746974 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment (ET) for type 2 ROP
Number of subjects: 317
Study 21746974 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM) for type 2 ROP
Number of subjects: 317
Study 21746974 — intervention group
Group type: COMPARATOR
Intervention: Overall ET vs CM for high-risk prethreshold ROP
Number of subjects: 317
Study 19282374 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 34
Study 19282374 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 34
Study 16961669 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural stress management programme
Number of subjects: 159
Study 16961669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 159
Study 15717708 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study 15717708 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study 15717708 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 60
Study 11762556 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 10 mg on days 6 to 10 and 25 mg on days 11 to 15 with furosemide 20 mg
Number of subjects: 26
Study 11762556 — intervention group
Group type: COMPARATOR
Intervention: Placebo with furosemide 20 mg
Number of subjects: 26
Study 8273240 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 1 mg
Number of subjects: 52
Study 8273240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 3799504 — intervention group
Group type: EXPERIMENTAL
Intervention: PUFA diet
Number of subjects: 6
Study 3799504 — intervention group
Group type: EXPERIMENTAL
Intervention: LO diet
Number of subjects: 6
Study 29486772 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverages containing bilberry
Number of subjects: 11
Study 29486772 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverages containing blackcurrant
Number of subjects: 11
Study 29486772 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverages containing mango
Number of subjects: 11
Study 29486772 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverages containing rose hip
Number of subjects: 11
Study 29486772 — intervention group
Group type: COMPARATOR
Intervention: Control (glucose drink)
Number of subjects: 11
Study 27473868 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidewire exchange (GWE)
Number of subjects: 178
Study 27473868 — intervention group
Group type: COMPARATOR
Intervention: Venipuncture insertion (VPI)
Number of subjects: 178
Study 25711332 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 424
Study 25711332 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 424
Study 23415190 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered, primary care-based intervention involving 6 weeks of interactive group classes followed by 6 months of culturally sensitive monthly coaching
Number of subjects: 41
Study 23415190 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 41
Study 20522410 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 82
Study 20522410 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy
Number of subjects: 82
Study 19544679 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4-metabolized statins (atorvastatin)
Number of subjects: 3
Study 19544679 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially-CYP3A4-metabolized statins (simvastatin)
Number of subjects: 3
Study 19544679 — intervention group
Group type: COMPARATOR
Intervention: Statin naive patients
Number of subjects: 3
Study 16635205 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-collected vaginal swabs
Number of subjects: 0
Study 16635205 — intervention group
Group type: COMPARATOR
Intervention: Provider-collected specimens
Number of subjects: 0
Study 16635205 — intervention group
Group type: EXPERIMENTAL
Intervention: Two swabs
Number of subjects: 0
Study 16635205 — intervention group
Group type: EXPERIMENTAL
Intervention: Two wicks
Number of subjects: 0
Study 15871555 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (NovoLog, NovoRapid)
Number of subjects: 0
Study 15871555 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 0
Study 15871555 — intervention group
Group type: COMPARATOR
Intervention: Biphasic insulin aspart (BIAsp30)
Number of subjects: 0
Study 15871555 — intervention group
Group type: COMPARATOR
Intervention: BIAsp30
Number of subjects: 0
Study 15871555 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart or BIAsp30
Number of subjects: 0
Study 10933570 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 75 to 300 mg
Number of subjects: 54
Study 10933570 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 25 to 150 mg
Number of subjects: 54
Study 9192124 — intervention group
Group type: EXPERIMENTAL
Intervention: celiprolol 200 mg
Number of subjects: 22
Study 9192124 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 50 mg
Number of subjects: 22
Study 9192124 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study 7901342 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel high dose (175 mg/m2)
Number of subjects: 18
Study 7901342 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel low dose (135 mg/m2)
Number of subjects: 18
Study 7901342 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 3-hour infusion schedule
Number of subjects: 18
Study 7901342 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 24-hour infusion schedule
Number of subjects: 18
Study 7901342 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (all treatment arms)
Number of subjects: 18
Study 3484922 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DS)
Number of subjects: 80